INVO Fertility, Inc.IVF

NasdaqHealthcareSurgical & Medical Instruments & Apparatus
Price (close)
$0.94
Market cap
—
P/E
—
Revenue (TTM)
$7.5M
Net income
-$7.0M
Dividend yield
—
1-year total return
-97.3%
Net margin
-92.3%
Revenue growth
13.8%
Debt / equity
0.10x

What INVO Fertility, Inc. does.

Annual Report on Form 10-K should be read together and in connection with the other reports that have been filed by us with the SEC for

a comprehensive description of our financial condition and operating results. In the interest of disclosure, we have included in this

Form 10-K certain material events and developments that have taken place through the date of filing of this Form 10-K with the SEC.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$1.0M$4.2M$822,196$3.0M$6.5M$6.8M
Net income-$8.3M-$6.7M-$10.9M-$8.0M-$9.3M-$23.3M
Free cash flow-$4.8M-$6.4M-$6.6M-$5.2M-$3.2M-$7.1M

More on IVF.

Figures from INVO Fertility, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.